瓣膜性-话题@MedSci - 梅斯（MedSci）

#瓣膜性#

56篇内容 | 1799人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1798237, encodeId=72b81e98237d7, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险, objectType=article, longId=83187, objectId=96138318e28, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96138318e28, replyNumber=0, likeNumber=76, createdTime=2017-02-06, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96138318e28, moduleTitle=JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=96138318e28)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798243, encodeId=2fe51e982439f, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林, objectType=article, longId=108547, objectId=c68710854ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68710854ef0, replyNumber=0, likeNumber=97, createdTime=2017-12-20, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68710854ef0, moduleTitle=Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c68710854ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798238, encodeId=733f1e98238ce, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=2017 ACC专家共识：非瓣膜性房颤患者围术期抗凝治疗的决策路径, objectType=article, longId=87250, objectId=95bb8e250c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95bb8e250c5, replyNumber=0, likeNumber=79, createdTime=2017-08-16, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95bb8e250c5, moduleTitle=2017 ACC专家共识：非瓣膜性房颤患者围术期抗凝治疗的决策路径, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=95bb8e250c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798236, encodeId=06fc1e98236fc, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布, objectType=article, longId=79986, objectId=4b64e998681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b64e998681, replyNumber=0, likeNumber=55, createdTime=2016-11-29, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b64e998681, moduleTitle=2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4b64e998681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798235, encodeId=0c6b1e9823569, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAMA Intern Med：利伐沙班会增加非瓣膜性房颤患者的颅内外出血风险, objectType=article, longId=79339, objectId=a7d0e933963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7d0e933963, replyNumber=0, likeNumber=73, createdTime=2017-06-12, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7d0e933963, moduleTitle=JAMA Intern Med：利伐沙班会增加非瓣膜性房颤患者的颅内外出血风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a7d0e933963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798239, encodeId=3cb11e982396a, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！, objectType=article, longId=89007, objectId=b5268900e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5268900e06, replyNumber=0, likeNumber=97, createdTime=2018-01-12, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5268900e06, moduleTitle=JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b5268900e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798234, encodeId=83591e9823422, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=JACC：亚洲非瓣膜性心房纤维性颤动患者服用利伐沙班和达比加群的疗效性分析, objectType=article, longId=78408, objectId=2ab4e840832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab4e840832, replyNumber=0, likeNumber=62, createdTime=2017-04-23, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab4e840832, moduleTitle=JACC：亚洲非瓣膜性心房纤维性颤动患者服用利伐沙班和达比加群的疗效性分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2ab4e840832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798233, encodeId=dcbf1e9823383, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=8 大要点搞定非瓣膜性房颤的抗凝治疗, objectType=article, longId=73524, objectId=7fd7e3524f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fd7e3524f1, replyNumber=0, likeNumber=79, createdTime=2017-01-20, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fd7e3524f1, moduleTitle=8 大要点搞定非瓣膜性房颤的抗凝治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7fd7e3524f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798232, encodeId=a0171e982326b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Stroke：达比加群不会增加亚洲非瓣膜性房颤患者的心血管疾病、出血等风险, objectType=article, longId=61854, objectId=ab1261854b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab1261854b7, replyNumber=0, likeNumber=64, createdTime=2016-04-03, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab1261854b7, moduleTitle=Stroke：达比加群不会增加亚洲非瓣膜性房颤患者的心血管疾病、出血等风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ab1261854b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798231, encodeId=06f01e98231b7, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=瓣膜性房颤知多少？, objectType=article, longId=59109, objectId=049c59109d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=049c59109d5, replyNumber=0, likeNumber=83, createdTime=2015-11-25, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=049c59109d5, moduleTitle=瓣膜性房颤知多少？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=049c59109d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798230, encodeId=1e9b1e9823076, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=EHJ：真实世界研究显示利伐沙班在非瓣膜性房颤患者中大出血率低（XANTUS研究）, objectType=article, longId=55885, objectId=02b955885b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b955885b8, replyNumber=0, likeNumber=62, createdTime=2016-02-14, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b955885b8, moduleTitle=EHJ：真实世界研究显示利伐沙班在非瓣膜性房颤患者中大出血率低（XANTUS研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02b955885b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798229, encodeId=bb671e9822925, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Stroke：非维生素K拮抗剂口服抗凝血药可预防亚洲非瓣膜性房颤患者脑卒中, objectType=article, longId=54306, objectId=ea5e543062a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea5e543062a, replyNumber=0, likeNumber=76, createdTime=2016-04-18, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea5e543062a, moduleTitle=Stroke：非维生素K拮抗剂口服抗凝血药可预防亚洲非瓣膜性房颤患者脑卒中, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ea5e543062a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798228, encodeId=a8211e98228e4, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=CFDA批准拜耳Xarelto（拜瑞妥）用于非瓣膜性房颤患者，预防中风及治疗深静脉血栓（DVT）, objectType=article, longId=50253, objectId=1f5a50253da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f5a50253da, replyNumber=0, likeNumber=51, createdTime=2016-02-22, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f5a50253da, moduleTitle=CFDA批准拜耳Xarelto（拜瑞妥）用于非瓣膜性房颤患者，预防中风及治疗深静脉血栓（DVT）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1f5a50253da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798227, encodeId=17d41e98227b7, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=FDA批准阿哌沙班预防非瓣膜性房颤患者卒中和栓塞, objectType=article, longId=13934, objectId=328713934ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=328713934ea, replyNumber=0, likeNumber=77, createdTime=2013-07-23, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=328713934ea, moduleTitle=FDA批准阿哌沙班预防非瓣膜性房颤患者卒中和栓塞, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=328713934ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798225, encodeId=b6631e98225f1, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=Stroke：2012AHA口服抗凝药治疗非瓣膜性房颤卒中建议, objectType=article, longId=8580, objectId=311085803d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=311085803d, replyNumber=0, likeNumber=70, createdTime=2013-01-27, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=311085803d, moduleTitle=Stroke：2012AHA口服抗凝药治疗非瓣膜性房颤卒中建议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=311085803d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1798226, encodeId=61f41e982265b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, objectTitle=中文版2012ESC 瓣膜性心脏病管理指南, objectType=article, longId=10818, objectId=164810818e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=164810818e6, replyNumber=0, likeNumber=78, createdTime=2012-10-26, rootId=0, userName=bshuang, userId=cdcd18, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=164810818e6, moduleTitle=中文版2012ESC 瓣膜性心脏病管理指南, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=164810818e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

瓣膜性

2020-05-29

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险

2017-02-06

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林

2017-12-20

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

2017 ACC专家共识：非瓣膜性房颤患者围术期抗凝治疗的决策路径

2017-08-16

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布

2016-11-29

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAMA Intern Med：利伐沙班会增加非瓣膜性房颤患者的颅内外出血风险

2017-06-12

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！

2018-01-12

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

JACC：亚洲非瓣膜性心房纤维性颤动患者服用利伐沙班和达比加群的疗效性分析

2017-04-23

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

8 大要点搞定非瓣膜性房颤的抗凝治疗

2017-01-20

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Stroke：达比加群不会增加亚洲非瓣膜性房颤患者的心血管疾病、出血等风险

2016-04-03

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

瓣膜性房颤知多少？

2015-11-25

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

EHJ：真实世界研究显示利伐沙班在非瓣膜性房颤患者中大出血率低（XANTUS研究）

2016-02-14

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Stroke：非维生素K拮抗剂口服抗凝血药可预防亚洲非瓣膜性房颤患者脑卒中

2016-04-18

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

CFDA批准拜耳Xarelto（拜瑞妥）用于非瓣膜性房颤患者，预防中风及治疗深静脉血栓（DVT）

2016-02-22

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

FDA批准阿哌沙班预防非瓣膜性房颤患者卒中和栓塞

2013-07-23

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

Stroke：2012AHA口服抗凝药治疗非瓣膜性房颤卒中建议

2013-01-27

bshuang (审核中...)

前往app查看评论内容

#瓣膜性#

中文版2012ESC 瓣膜性心脏病管理指南

2012-10-26

科室
- - 订阅+
  - 更多科室
工具
服务